review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | G. David Roodman | |
P2860 | cites work | RANK is essential for osteoclast and lymph node development | Q24598872 |
Src kinase activity is essential for osteoclast function | Q28513236 | ||
ADAM8: a novel osteoclast stimulating factor | Q28588620 | ||
Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand | Q30670375 | ||
Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption | Q30773401 | ||
Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor | Q30961251 | ||
Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment | Q34247917 | ||
Osteopetrosis | Q34380528 | ||
Mechanisms involved in bone resorption | Q34641090 | ||
CytokineRegulation and the signaling mechanism of osteoclast inhibitory peptide-1 (OIP-1/hSca) to inhibit osteoclast formation | Q40666292 | ||
B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta | Q40875461 | ||
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells | Q40927574 | ||
Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. | Q41121255 | ||
Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation | Q42475736 | ||
A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function | Q42811314 | ||
Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment | Q43755563 | ||
Bifurcation of osteoclasts and dendritic cells from common progenitors | Q43757343 | ||
Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index | Q44032751 | ||
NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis | Q44049672 | ||
Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures | Q44058149 | ||
p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function | Q44072080 | ||
M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase | Q44591611 | ||
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1. | Q46375837 | ||
Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation | Q57675158 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | A disintegrin and metallopeptidase domain 8 | Q21495343 |
P304 | page(s) | 100–109 | |
P577 | publication date | 2006-04-01 | |
P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
P1476 | title | Regulation of osteoclast differentiation | |
P478 | volume | 1068 |
Q48000639 | A novel ex vivo culture model for inflammatory bone destruction |
Q34028709 | Activating transcription factor 4 regulates osteoclast differentiation in mice. |
Q42150169 | Adam8 limits the development of allergic airway inflammation in mice. |
Q37318849 | Advances in osteoclast biology resulting from the study of osteopetrotic mutations. |
Q52640427 | Anxa2 attenuates osteoblast growth and is associated with hip BMD and osteoporotic fracture in Chinese elderly. |
Q38995801 | BMP-2 and titanium particles synergistically activate osteoclast formation |
Q43902819 | Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. |
Q35798517 | Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health |
Q93029052 | Brief Review on Metabolic Bone Disease |
Q41875199 | Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors |
Q34460755 | Characterization and identification of subpopulations of mononuclear preosteoclasts induced by TNF-α in combination with TGF-β in rats |
Q34077850 | Characterization of the response of primary cells relevant to dialysis-related amyloidosis to β2-microglobulin monomer and fibrils |
Q37609556 | Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-κB, ERK and JNK signaling pathways |
Q33332122 | Complex dynamics of osteoclast formation and death in long-term cultures |
Q27653392 | Crystal structure of human osteoclast stimulating factor |
Q42467215 | Differential production of macrophage inflammatory protein-1alpha, stromal-derived factor-1, and IL-6 by human cultured periodontal ligament and gingival fibroblasts challenged with lipopolysaccharide from P. gingivalis. |
Q39664895 | Double stranded RNA-dependent protein kinase is involved in osteoclast differentiation of RAW264.7 cells in vitro |
Q33784120 | Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro |
Q36357434 | Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension |
Q37809213 | Evolution of the parathyroid hormone family and skeletal formation pathways |
Q38342243 | Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain. |
Q33779830 | Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia |
Q36544723 | Functional osteoclastogenesis: the baseline variability in blood donor precursors is not associated with age and gender |
Q33699188 | Gene targeting to the stroma of the prostate and bone |
Q39656727 | Identification of Osteoclastic Factors in the Nuclear Envelope of Mature, Multinucleated Osteoclasts |
Q33816415 | Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine. |
Q34059293 | Important roles of PI3Kgamma in osteoclastogenesis and bone homeostasis |
Q58274650 | In vitro cholesteatoma growth and secretion of cytokines |
Q34148428 | Increased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim/oim mouse model of osteogenesis imperfecta |
Q37131738 | Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone |
Q47730277 | Inhibitory effects of sesamin on human osteoclastogenesis |
Q36908519 | Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence |
Q36835789 | Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy |
Q39922305 | Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice |
Q34243554 | Krüppel-like factor 4 regulates membranous and endochondral ossification |
Q33799794 | Loss of functional NADPH oxidase 2 protects against alcohol-induced bone resorption in female p47phox-/- mice. |
Q51742926 | Magnesium-enriched hydroxyapatite versus autologous bone in maxillary sinus grafting: combining histomorphometry with osteoblast gene expression profiles ex vivo. |
Q36553375 | Measles virus nucleocapsid protein, a key contributor to Paget's disease, increases IL-6 expression via down-regulation of FoxO3/Sirt1 signaling |
Q33758838 | Measurement by vertical scanning profilometry of resorption volume and lacunae depth caused by osteoclasts on dentine slices |
Q47118982 | Mesenchymal stem cells inhibit RANK-RANKL interactions between osteoclasts and Th17 cells via osteoprotegerin activity |
Q37729189 | Methyl Gallate Inhibits Osteoclast Formation and Function by Suppressing Akt and Btk-PLCγ2-Ca2+ Signaling and Prevents Lipopolysaccharide-Induced Bone Loss. |
Q34527129 | MicroRNAs involved in bone formation. |
Q36745236 | Microstructured titanium regulates interleukin production by osteoblasts, an effect modulated by exogenous BMP-2 |
Q38091023 | Neoplastic bone marrow niche: hematopoietic and mesenchymal stem cells |
Q40468875 | Network-based proteomic analysis for postmenopausal osteoporosis in Caucasian females. |
Q34286289 | Novel method of murine embryonic stem cell-derived osteoclast development |
Q59797072 | Nox2 Activity Is Required in Obesity-Mediated Alteration of Bone Remodeling |
Q28274725 | Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity |
Q34696114 | Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss |
Q38124052 | Osteoporosis in older persons: current pharmacotherapy and future directions |
Q39445928 | Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State. |
Q36453271 | Patient specific proteolytic activity of monocyte-derived macrophages and osteoclasts predicted with temporal kinase activation states during differentiation. |
Q38568957 | Peripheral Blood Mononuclear Cells Spontaneous Osteoclastogenesis: Mechanisms Driving the Process and Clinical Relevance in Skeletal Disease |
Q35579638 | Peripheral blood monocyte-expressed ANXA2 gene is involved in pathogenesis of osteoporosis in humans |
Q35156112 | Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling |
Q30656758 | Prostate cancer invasion and metastasis: insights from mining genomic data |
Q37716325 | Quantitative proteomics and integrative network analysis identified novel genes and pathways related to osteoporosis |
Q47619382 | Relationship between A163G osteoprotegerin gene polymorphism and other osteoporosis parameters in Roma and non-Roma postmenopausal women in eastern Slovakia. |
Q92377250 | Rev-erbα Negatively Regulates Osteoclast and Osteoblast Differentiation through p38 MAPK Signaling Pathway |
Q41726644 | Role of Wnt signaling in bone remodeling and repair |
Q33597248 | Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells |
Q34983694 | Salivary biomarkers of periodontal disease in response to treatment |
Q48049809 | Study of bone metabolism and angiogenesis in patients undergoing high-dose chemotherapy/autologous hematopoietic stem cell transplantation. |
Q26765491 | The Alternative Faces of Macrophage Generate Osteoclasts |
Q28586398 | The LIM protein LIMD1 influences osteoblast differentiation and function |
Q26773017 | The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis |
Q33873578 | The critical role of IL-34 in osteoclastogenesis |
Q37423147 | The molecular mechanism behind bone remodelling: a review |
Q47764004 | The potential of mangosteen (Garcinia mangostana) peel extract, combined with demineralized freeze-dried bovine bone xenograft, to reduce ridge resorption and alveolar bone regeneration in preserving the tooth extraction socket |
Q21195416 | Tumor metastasis to bone |
Q42139802 | Ubiquitin E3 Ligase LNX2 is Critical for Osteoclastogenesis In Vitro by Regulating M-CSF/RANKL Signaling and Notch2. |
Q36759374 | Understanding and targeting osteoclastic activity in prostate cancer bone metastases |